What is the market capitalization of HEMOSTEMIX INC?

HEMOSTEMIX INC (HEM.V) has a market capitalization of approximately 11,869,286 CAD.

Where can I buy HEM.V in Canada?

HEM.V can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

HEM.V

HEMOSTEMIX INC

HEMOSTEMIX INC (HEM.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 12 million CAD (micro-cap).

Details

Price0.06 CAD

Market cap11.87 M CAD

Payout ratio0.00%

SectorHealthcare

Websitehemostemix.com

Updated 3h ago

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.